Opus Genetics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 38.7% | 38.7% | 36.5% |
| FY2023 | -20.0% | -20.0% | -18.5% |
| FY2024 | -855.6% | -855.6% | -156.1% |
| FY2025 | -323.1% | -301.0% | -98.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 38.7% | 38.7% | 36.5% |
| FY2023 | -20.0% | -20.0% | -18.5% |
| FY2024 | -855.6% | -855.6% | -156.1% |
| FY2025 | -323.1% | -301.0% | -98.7% |